Bispecific PSMA-617 / RM2 Heterodimer for Theranostics Applications in Prostate Cancer
Bispecific PSMA-617 / RM2 Heterodimer for Theranostics Applications in Prostate Cancer
About this item
Full title
Author / Creator
Publisher
Washington: American Chemical Society
Journal title
Language
English
Formats
Publication information
Publisher
Washington: American Chemical Society
Subjects
More information
Scope and Contents
Contents
PSMA and GRPR protein receptors are upregulated during prostate cancer (PCa) progression, and thus they have both been used for diagnostic molecular imaging and therapy of the disease. To address tumor heterogeneity, we synthesized and evaluated the bispecific PSMA/GRPR ligand (3) with a 10 atom spacer between PSMA-617 (1) and the GRPR antagonist R...
Alternative Titles
Full title
Bispecific PSMA-617 / RM2 Heterodimer for Theranostics Applications in Prostate Cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2913189927
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2913189927
Other Identifiers
E-ISSN
2573-2293
DOI
10.26434/chemrxiv-2024-ldvx9
